Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | TP53 | P04637 | 1/20 | 0.30 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18843101 | 0.90 | — | — | |
| SCHEMBL18843140 | 0.90 | — | — | |
| SCHEMBL18843115 | 0.89 | LMNA (0.30) | LMNATP53RXFP1 | |
| SCHEMBL18843107 | 0.89 | VCAM1 (0.32) | — | |
| SCHEMBL18843103 | 0.88 | ATM (0.30) | — | |
| SCHEMBL18843124 | 0.81 | — | — | |
| SCHEMBL18843166 | 0.80 | VCAM1 (0.31) | — | |
| SCHEMBL18843111 | 0.79 | VCAM1 (0.31) | — | |
| SCHEMBL18843133 | 0.78 | — | — | |
| SCHEMBL18843121 | 0.77 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170133605-A1 | TETRACENOTHIOPHENE DERIVATIVES WITH ALKOXY-C-ALKYNE SOLUBILISING UNITS AND THEIR APPLICATIONS AS ORGANIC SEMICONDUCTORS | CAMBRIDGE DISPLAY TECHNOLOGY LIMITED (GB) | 2017-05-11 | — | — | US | disclosed |
| US-20170133605-A1 | TETRACENOTHIOPHENE DERIVATIVES WITH ALKOXY-C-ALKYNE SOLUBILISING UNITS AND THEIR APPLICATIONS AS ORGANIC SEMICONDUCTORS | CAMBRIDGE DISPLAY TECHNOLOGY LIMITED (GB) | 2017-05-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170133605-A1 | TETRACENOTHIOPHENE DERIVATIVES WITH ALKOXY-C-ALKYNE SOLUBILISING UNITS AND THEIR APPLICATIONS AS ORGANIC SEMICONDUCTORS | ALK, TPR, TTI2 | LMNA 1692/4885TP53 4004/4885RXFP1 4651/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.